- Chair Profesoor, HKU
- Director, State Key Laboratory of Pharmaceutical Biotechnology
Professor Xu Aimin is a chair professor jointly appointed by the Department of Medicine and the Department of Pharmacology and Pharmacy at the University of Hong Kong. He also serves as the Director of the State Key Laboratory of Pharmaceutical Biotechnology, leading a team focusing on research on metabolic chronic diseases and related biomedical developments. Since joining the University of Hong Kong, he has made numerous original contributions in research areas such as peptide hormones secreted by fat and liver. He has published over 350 research articles, invited reviews, and commentaries in renowned journals including Cell Metabolism, Nature Metabolism, Nature Reviews Endocrinology, Circulation, European Heart Journal, Journal of Hepatology, with over 46,500 citations and an H-index of 113. In the past decade, Professor Xu has been consistently recognized as one of the top 1% of global scientific researchers by Clarivate Analytics.